HC Wainwright reaffirmed their buy rating on shares of IO Biotech (NASDAQ:IOBT – Free Report) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $8.00 price objective on the stock. IO Biotech Price Performance Shares of NASDAQ IOBT opened at $1.82 on Wednesday. IO Biotech has a 1 year […]
Holdings A/S Novo Sells 658,809 Shares of IO Biotech, Inc. (NASDAQ:IOBT) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Recommendation of "Moderate Buy" by Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Wedbush in a report released on Tuesday, Benzinga reports. They presently have a $15.00 target price on the stock. Wedbush’s target price suggests a potential upside of 172.73% from the stock’s current price. Separately, Needham & Company […]
Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $10.22 and last traded at $10.21, with a volume of 474243 shares traded. The stock had previously closed at $10.18. Wall Street Analysts Forecast Growth Several research firms […]